82
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)

, , , , , , & show all
Pages 3109-3120 | Published online: 16 Jul 2021

References

  • Tao LW, Wu Z, Guymer RH, Luu CD. Ellipsoid zone on optical coherence tomography: a review. Clin Exp Ophthalmol. 2016;44(5):422–430. doi:10.1111/ceo.12685
  • Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina. 2011;31(8):1609–1619. doi:10.1097/IAE.0b013e3182247535
  • Zhu W, Chen H, Zhao H, et al. Automatic three-dimensional detection of photoreceptor ellipsoid zone disruption caused by trauma in the OCT. Sci Rep. 2016;6:25433. doi:10.1038/srep25433
  • García-Layana A, García-Arumí J, Ruiz-Moreno JM, Arias-Barquet L, Cabrera-López F, Figueroa MS. A review of current management of vitreomacular traction and macular hole. J Ophthalmol. 2015;2015:809640. doi:10.1155/2015/809640
  • Saxena S, Srivastav K, Cheung CM, Ng JYW, Lai TYY. Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomography. Clin Ophthalmol. 2014;8:2507–2522. doi:10.2147/OPTH.S72132
  • Maheshwary AS, Oster SF, Yuson RMS, Cheng L, Mojana F, Freeman WR. The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol. 2010;150(1):63–67 e1. doi:10.1016/j.ajo.2010.01.039
  • Oster SF, Mojana F, Brar M, Yuson RMS, Cheng L, Freeman WR. Disruption of the photoreceptor inner segment/outer segment layer on spectral domain-optical coherence tomography is a predictor of poor visual acuity in patients with epiretinal membranes. Retina. 2010;30(5):713–718. doi:10.1097/IAE.0b013e3181c596e3
  • Stalmans P, Benz MS, Gandorfer A, et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367(7):606–615. doi:10.1056/NEJMoa1110823
  • Nudleman E, Franklin MS, Wolfe JD, Williams GA, Ruby AJ. Resolution of subretinal fluid and outer retinal changes in patients treated with ocriplasmin. Retina. 2016;36(4):738–743. doi:10.1097/IAE.0000000000000755
  • Singh RP, Li A, Bedi R, et al. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol. 2014;98(3):356–360. doi:10.1136/bjophthalmol-2013-304219
  • Tibbetts MD, Reichel E, Witkin AJ. Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography. JAMA Ophthalmol. 2014;132(4):487–490. doi:10.1001/jamaophthalmol.2013.8258
  • Itoh Y, Ehlers JP. Ellipsoid zone mapping and outer retinal characterization after intravitreal ocriplasmin. Retina. 2016;36(12):2290–2296. doi:10.1097/IAE.0000000000001110
  • Freund KB, Shah SA, Shah VP. Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin. Eye (Lond). 2013;27(6):773–774. doi:10.1038/eye.2013.94
  • Khanani AM, Duker JS, Heier JS, et al. Ocriplasmin treatment leads to symptomatic vitreomacular adhesion/vitreomacular traction resolution in the real-world setting: the Phase IV ORBIT study. Ophthalmol Retina. 2019;3(1):32–41. doi:10.1016/j.oret.2018.07.011
  • Sharma P, Juhn A, Houston SK, et al. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes. Am J Ophthalmol. 2015;159(5):861–867. doi:10.1016/j.ajo.2015.01.034
  • Lavine JA, Srivastava SK, Dukkles N, Reese JL, Ehlers JP. Longitudinal ellipsoid zone and subretinal fluid mapping following ocriplasmin injection in the prospective observational ORBIT trial. Br J Ophthalmol. 2020;104(3):410–415. doi:10.1136/bjophthalmol-2019-314142
  • Duker JS, Kaiser PK, Binder S, et al. The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120(12):2611–2619. doi:10.1016/j.ophtha.2013.07.042
  • Fukumoto M, Sato T, Oosuka S, Kida T, Oku H, Ikeda T. Clinical features of vitreomacular traction syndrome with peripheral vitreoretinal adhesion. Clin Ophthalmol. 2020;14:281–286. doi:10.2147/OPTH.S235670
  • Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A. Results of the 2-year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) randomized trial. Ophthalmology. 2016;123(10):2232–2247. doi:10.1016/j.ophtha.2016.06.043